Answers are grounded in this paper and cite their sources.
Chronic myeloproliferative diseases (CMPD) are clonal diseases that may cause hemostatic and thrombotic abnormalities. They progress to acute leukemia and are characterized by increases in the number of mature and immature cells in the peripheral blood as a result of uncontrolled proliferation of one or more than one type of myeloerythroid cells in the bone marrow. This study aimed to determine demographic features, incidence of Janus kinase 2 (JAK2) mutations, disease characteristics, and treatment strategies in patients diagnosed with CMPD.
No takes yet. Share an insight, caveat, or question.
Çekdemir et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: